DiscoverThe Top LineA look at flu vaccine manufacturing and supply in the post-pandemic era
A look at flu vaccine manufacturing and supply in the post-pandemic era

A look at flu vaccine manufacturing and supply in the post-pandemic era

Update: 2024-09-06
Share

Description

In this week's episode of "The Top Line," we’re looking at what goes into manufacturing and supply of flu vaccines. 

Fierce Pharma’s Zoey Becker chats with Stefan Merlo, vice president of commercial operations, North America at CSL Seqirus. He discusses the company's differentiated flu vaccine portfolio and how its manufacturing process has evolved over the decades to create and distribute vaccines offering targeted protection each year.

To learn more about the topics in this episode: 

See omnystudio.com/listener for privacy information.

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

A look at flu vaccine manufacturing and supply in the post-pandemic era

A look at flu vaccine manufacturing and supply in the post-pandemic era

Fierce Life Sciences